Oral alendronate in osteogenesis imperfecta.

Simple item page
dc.contributor.authorUnal, Edipen_US
dc.contributor.authorAbaci, Ayhanen_US
dc.contributor.authorBober, Eceen_US
dc.contributor.authorBuyukgebiz, Atillaen_US
dc.date.accessioned2005-11-13en_US
dc.date.accessioned2009-05-27T05:52:20Z
dc.date.available2005-11-13en_US
dc.date.available2009-05-27T05:52:20Z
dc.date.issued2005-11-13en_US
dc.description.abstractWe report a case of Osteogenesis Imperfecta (OI) in an eight-year-old boy who was admitted with complaints of recurrent long bone fractures. With oral alendronate treatment significant increment occurred in the bone mineral density and the number of fractures decreased. The usage of oral bisphosphonates is inexpensive and easy to administer in selected cases of OI. This case report supports the usage of oral alendronate treatment as an alternative treatment in OI.en_US
dc.description.affiliationDepartment of Pediatrics, and Division of Endocrinology, Dokuz Eylul University, Faculty of Medicine, Inciralti-Izmir, Turkey.en_US
dc.identifier.citationUnal E, Abaci A, Bober E, Buyukgebiz A. Oral alendronate in osteogenesis imperfecta. Indian Pediatrics. 2005 Nov; 42(11): 1158-60en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/13643
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAdministration, Oralen_US
dc.subject.meshAlendronate --therapeutic useen_US
dc.subject.meshBone Density Conservation Agents --therapeutic useen_US
dc.subject.meshChilden_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshOsteogenesis Imperfecta --drug therapyen_US
dc.titleOral alendronate in osteogenesis imperfecta.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Pediatrics